{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:03:23Z","timestamp":1790388203969,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ibroneuroreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IBRO Neuroscience Reports"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ibneur.2023.02.006","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T16:50:51Z","timestamp":1697475051000},"page":"162-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Correlation between 25-hydroxy-vitamin D and Parkinson's disease"],"prefix":"10.1016","volume":"16","author":[{"given":"Ming","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjiu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ibneur.2023.02.006_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0625.2010.01201.x","article-title":"VitaminD production depends on ultraviolet-B dose but not on dose rate:a randomized controlled trial","volume":"20","author":"Bogh","year":"2011","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ibneur.2023.02.006_bib2","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.0b013e3182a95818","article-title":"Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard biomarker study","volume":"81","author":"Ding","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ibneur.2023.02.006_bib3","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/nu2050482","article-title":"The relationship between ultraviolet radiation exposure and vitamin D status","volume":"2","author":"Engelsen","year":"2010","journal-title":"Nutrients"},{"key":"10.1016\/j.ibneur.2023.02.006_bib4","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/archneurol.2011.30","article-title":"High prevalence of hypovitaminosis D status in patients with early Parkinson disease","volume":"68","author":"Evatt","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ibneur.2023.02.006_bib5","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1001\/archneur.65.10.1348","article-title":"Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease","volume":"65","author":"Evatt","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ibneur.2023.02.006_bib6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3389\/fneur.2020.00454","article-title":"A review of the relationship between vitamin D and Parkinson disease symptoms","volume":"11","author":"Fullard","year":"2020","journal-title":"Front Neurol."},{"key":"10.1016\/j.ibneur.2023.02.006_bib7","first-page":"310","article-title":"Vitamin D deficiency and the clinical consequences","volume":"119","author":"Galesanu","year":"2015","journal-title":"Rev. Med. Chir. Soc. Med. Nat. Lasi"},{"issue":"3","key":"10.1016\/j.ibneur.2023.02.006_bib8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ibneur.2023.02.006_bib9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ibneur.2023.02.006_bib10","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.ibneur.2023.02.006_bib11","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archneurol.2010.120","article-title":"Serum vitamin D and the risk of Parkinson disease","volume":"67","author":"Knekt","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ibneur.2023.02.006_bib12","first-page":"525","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"5","author":"de Lau","year":"2006"},{"key":"10.1016\/j.ibneur.2023.02.006_bib13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00415-016-8370-2","article-title":"MDS clinical diagnostic criteria for Parkinson's disease in China","volume":"264","author":"Li","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.ibneur.2023.02.006_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40734-018-0074-6","article-title":"NINDS NET-PD investigators. Characterization of vitamin D supplementation and clinical outcomes in a large cohort of early Parkinson's disease","volume":"5","author":"Luthra","year":"2018","journal-title":"J. Clin. Mov. Disord."},{"issue":"9","key":"10.1016\/j.ibneur.2023.02.006_bib15","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1373\/clinchem.2005.052936","article-title":"Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3","volume":"51","author":"Maunsell","year":"2005","journal-title":"Clin. Chem."},{"issue":"Suppl 1","key":"10.1016\/j.ibneur.2023.02.006_bib16","article-title":"Association between serum biochemical levels, related to bone metabolism and Parkinson's disease","volume":"18","author":"Meamar","year":"2013","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.ibneur.2023.02.006_bib17","doi-asserted-by":"crossref","DOI":"10.1097\/MCG.0000000000000606","article-title":"Gastrointestinal dysfunction and neuropathologic correlations in Parkinson disease","volume":"50","author":"Mrabet","year":"2016","journal-title":"J. Clin. Gastroenterol."},{"issue":"21 Suppl 4","key":"10.1016\/j.ibneur.2023.02.006_bib18","article-title":"Stern MBSK,Sethi K. The scientific and clinical basis for the treatment of Parkinson disease","volume":"72","author":"Olanow","year":"2009","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ibneur.2023.02.006_bib19","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/mds.25405","article-title":"The relationship between balance control and vitamin D in Parkinson\u2019s disease a pilot study","volume":"28","author":"Peterson","year":"2013","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.ibneur.2023.02.006_bib20","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.3390\/biomedicines9101284","article-title":"The role of vitamins in neurodegenerative disease: an update","volume":"9","author":"Rai","year":"2021","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.ibneur.2023.02.006_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1212\/WNL.49.5.1273","article-title":"High prevalence of vitamin D deficiency and reduced bone mass in Parkinson\u2019s disease","volume":"49","author":"Sato","year":"1997","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ibneur.2023.02.006_bib22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1053\/apmr.2002.27376","article-title":"Vitamin K deficiency and osteopenia in vitamin D\u2010deficient elderly women with Parkinson\u2019s disease","volume":"83","author":"Sato","year":"2002","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.ibneur.2023.02.006_bib23","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/mds.20658","article-title":"Abnormal bone and calcium metabolism in immobilized Parkinson\u2019s disease patients","volume":"12","author":"Sato","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ibneur.2023.02.006_bib24","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/mds.26573","article-title":"Serum 25-hydroxyvitamin D concentrations in mid-adulthood and Parkinson's disease risk","volume":"31","author":"Shrestha","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ibneur.2023.02.006_bib25","first-page":"669","article-title":"The role of vitamin D in disease progression in early Parkinson's disease","volume":"7","author":"Sleeman","year":"2017","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.ibneur.2023.02.006_bib26","first-page":"669","article-title":"The role of vitamin D in disease progression in early Parkinson\u2019s disease","volume":"7","author":"Sleeman","year":"2017","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.ibneur.2023.02.006_bib27","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2147\/TCRM.S3552","article-title":"The use of calcium and vitamin D in the management of osteoporosis","volume":"4","author":"Sunyecz","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.ibneur.2023.02.006_bib28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/mds.24016","article-title":"25-hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson\u2019s disease","volume":"27","author":"Suzuki","year":"2012","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.ibneur.2023.02.006_bib29","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3945\/ajcn.112.051664","article-title":"Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease","volume":"97","author":"Suzuki","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ibneur.2023.02.006_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/nu5010111","article-title":"Vitamin D-effects on skeletal and extraskeletal health and the need for supplementation","volume":"5","author":"Wacker","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.ibneur.2023.02.006_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4161\/derm.24494","article-title":"Sunlight and vitamin D: a global perspective for health","volume":"5","author":"Wacker","year":"2013","journal-title":"Derm. - Endocrinol."},{"issue":"3","key":"10.1016\/j.ibneur.2023.02.006_bib32","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/nu8030142","article-title":"Vitamin D and sunlight exposure in newly-diagnosed Parkinson\u2019s disease","volume":"8","author":"Wang","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.ibneur.2023.02.006_bib33","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/mds.26117","article-title":"Vitamin D from different sources is inversely associated with Parkinson disease","volume":"30","author":"Wang","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ibneur.2023.02.006_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2014.09.024","article-title":"High prevalence of vitamin D deficiency among middle-aged and elderly individuals in northwestern China: its relationship to osteoporosis and lifestyle factors","volume":"71","author":"Zhen","year":"2015","journal-title":"Bone"}],"container-title":["IBRO Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242123000167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242123000167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:04:16Z","timestamp":1723853056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667242123000167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":34,"alternative-id":["S2667242123000167"],"URL":"https:\/\/doi.org\/10.1016\/j.ibneur.2023.02.006","relation":{},"ISSN":["2667-2421"],"issn-type":[{"value":"2667-2421","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between 25-hydroxy-vitamin D and Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"IBRO Neuroscience Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ibneur.2023.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd on behalf of International Brain Research Organization.","name":"copyright","label":"Copyright"}]}}